Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Lly save search
Global Branded PAH Therapeutics Market Report 2023-2029 - Targeted Therapies Revolutionize Treatment, Growing Prevalence Spurs Market Expansion for Branded Therapeutics
Published: 2023-12-15 (Crawled : 02:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
report expansion global growing therapeutics market
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
Published: 2023-12-14 (Crawled : 12:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: 0.0%
BEAM | $24.33 0.08% 0.08% 1.7M
|
Health Technology
|
| O: 3.61%
H: 3.21%
C: 1.67%
biotech therapeutics
Metastatic Prostate Cancer Market to Exhibit Positive Growth at a CAGR of 22% and 7.5% for mHSPC and mCRPC, respectively During the Study Period (2019-2032), Assesses DelveInsight
Published: 2023-12-13 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
positive cancer growth study market
As Its Domestic Market Grows, South Africa Moves Toward Greater Local Biophar...
Published: 2023-12-13 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.06%
H: 2.36%
C: 2.36%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.27%
H: 2.28%
C: 2.16%
market africa
As Its Domestic Market Grows, South Africa Moves Toward Greater Local Biopharmaceutical Production
Published: 2023-12-13 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.06%
H: 2.36%
C: 2.36%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.71%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.27%
H: 2.28%
C: 2.16%
market africa
Innovent Announces Inclusion in the China National Reimbursement Drug List of TYVYT® 's Seventh Indication and BYVASDA®'s Eighth Indication
Published: 2023-12-13 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.06%
H: 2.36%
C: 2.36%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.27%
H: 2.28%
C: 2.16%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.95%
H: 3.83%
C: 2.79%
tyvyt drug china
HUTCHMED Announces Continued Inclusion of ELUNATE® (fruquintinib) and SULANDA® (surufatinib) in the National Reimbursement Drug List in China at Current Terms
Published: 2023-12-13 (Crawled : 05:00) - globenewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.32%
H: 0.0%
C: 0.0%
HCM | $16.38 -0.43% -0.43% 190K
|
Health Technology
|
| O: -2.54%
H: 3.89%
C: 3.41%
elunate drug china
Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient Quality of Life
Published: 2023-12-12 (Crawled : 22:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
LGND | News | $72.61 -7.94% -8.62% 130K
|
Health Technology
|
| O: 0.21%
H: 1.18%
C: 0.43%
breast life cancer pharmaceuticals results
Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, Expands Leadership Team to Support Further Development
Published: 2023-12-12 (Crawled : 17:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
candidate parkinson’s
Allarity Therapeutics Announces Thomas Jensen as Interim CEO and Appointment of Jeremy R. Graff, PhD as Key Executive Advisor
Published: 2023-12-12 (Crawled : 11:00) - globenewswire.com
ALLR | News | $1.53 2.0% 1.96% 760K
|
n/a
|
| O: -2.26%
H: 9.41%
C: 7.03%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
ceo therapeutics
Updated Data from the BRUIN Phase 1/2 Study of Pirtobrutinib in Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma Presented at the 2023 ASH Annual Meeting
Published: 2023-12-12 (Crawled : 01:00) - prnewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
cell meeting leukemia study
Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of Oncology
Published: 2023-12-11 (Crawled : 20:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
LGND | News | $72.61 -7.94% -8.62% 130K
|
Health Technology
|
| O: 0.29%
H: 1.26%
C: 0.87%
publication pharmaceuticals trial results
Lilly's Zepbound™ (tirzepatide) achieved additional 6.7% weight loss following a 36-week open-label lead-in period, for a total mean weight loss of 26.0% from study entry over 88 weeks
Published: 2023-12-11 (Crawled : 16:00) - prnewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
total study tirzepatide
Global Premature Ejaculation Therapeutics Market Report 2024-2029: North America and Europe Dominate the Market in 2023, APAC Emerges as the Fastest-Growing Market
Published: 2023-12-08 (Crawled : 20:00) - prnewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
america europe report global therapeutics market
ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets
Published: 2023-12-08 (Crawled : 12:30) - globenewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
PRQR | $1.86 -2.11% -2.15% 180K
|
Health Technology
|
| O: 0.49%
H: 3.9%
C: -2.44%
acquire therapeutics
Red Biotechnology Market to Reach $1,513.22 Billion, Globally, by 2030 at 10.7% CAGR: Coherent Market Insights
Published: 2023-12-08 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.594 43.47% 2.2K
|
Health Technology
|
| O: -2.79%
H: 0.62%
C: 0.62%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.29%
H: 0.4%
C: 0.4%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: -2.2%
H: 0.0%
C: -0.27%
TAK | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: -0.64%
H: 0.5%
C: 0.5%
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.42%
H: 0.67%
C: 0.25%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.19%
H: 0.35%
C: 0.2%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.2%
H: 0.55%
C: 0.1%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
GILD | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.08%
H: 1.45%
C: 1.17%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.05%
H: 0.3%
C: -0.76%
reach market
FDA Roundup: December 5, 2023
Published: 2023-12-05 (Crawled : 14:30) - fda.gov
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
fda
Metastatic Castration-Sensitive Prostate Cancer Market to Skyrocket at Astounding 22% CAGR During the Study Period (2019-2032), assesses DelveInsight
Published: 2023-12-06 (Crawled : 22:00) - prnewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
cancer study market
The Top 12 Biopharma Companies Hiring Now
Published: 2023-12-06 (Crawled : 22:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
companies biopharma
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
DNLI | $16.6 -1.31% -1.33% 1.2M
|
Health Technology
|
| O: 0.05%
H: 5.74%
C: 3.18%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.42%
H: 2.37%
C: 1.45%
disease parkinson's revenue research therapeutics market
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.